RxDoctor Payments Data

Peter Gerszten

Neurosurgery · Pittsburgh, PANPI 1891768883

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 63.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $18,679 and has fallen 92.8% since, to $1,352 in 2025.

$38,017in general payments, 2019–2025

Across 73 payments — averaging $520.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$24K
  • Zimmer Biomet$10K
  • Globus Medical$1K
  • Stryker$893
  • Cerapedics Inc.$441
  • Zap Surgical Systems, Inc.$231
  • plus $647 from 5 others
$45,580in research payments, 2019–2025

Across 9 payments — averaging $5064.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cerapedics Inc.$46K

What the payments were for

  • Consulting fees$9,62525%
  • Speaking & faculty fees$21,70057%
  • Travel & lodging$2,6557%
  • Food & beverage$4,03711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)28$24,286
Zimmer Biomet19$10,445
Globus Medical6$1,072
Stryker10$893
Cerapedics Inc.4$441
Zap Surgical Systems, Inc.1$231
Carlsmed, Inc.1$182
Amgen1$140
Icotec Medical Inc.1$138
Kuros Biosciences USA, Inc1$98
Johnson & Johnson1$89

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$231,001
Medicare patients
169
Services billed
596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl86$486
Methocarbamol76$380
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$118
Cyclobenzaprine Hcl14$19
Diazepam12$17

Paid to pharmacies, not to this prescriber.

Other neurosurgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →